GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also ...

Last week's rumour that GSK was poised to make a bid to acquire ... The deal coincides with the start of the JP Morgan healthcare conference in San Francisco, which has become a popular venue ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022 ...

GSK (NYSE:GSK) shares rose for seven straight sessions, as the stock ended 0.7% higher at $40.32 on Monday. The pharmaceutical giant gained over 6.5% in the preceding six sessions. The stock has ...

as announced on the fourth-quarter conference call. In February, GSK said it expects to generate sales of more than £40 billion by 2031, an increase from its previous projection of more than £38 ...